Frazier Management LLC Tarsus Pharmaceuticals, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$14.49 - $24.28 $20.5 Million - $34.4 Million
-1,417,157 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$27.16 - $38.59 $13.6 Million - $19.3 Million
-500,000 Reduced 26.08%
1,417,157 $41.1 Million
Q4 2020

Feb 11, 2021
BUY
$19.17 - $49.62 $36.8 Million - $95.1 Million
1,917,157 New
1,917,157 $79.2 Million

Others Institutions Holding TARS

# of Institutions
170
Shares Held
43.3M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.24B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email